ALDX
Price
$5.34
Change
+$0.09 (+1.71%)
Updated
Oct 14 closing price
Capitalization
320.64M
29 days until earnings call
Intraday Buy/Sell Signals
MGTX
Price
$7.93
Change
+$0.10 (+1.28%)
Updated
Oct 14 closing price
Capitalization
637.95M
22 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ALDX vs MGTX

Header iconALDX vs MGTX Comparison
Open Charts ALDX vs MGTXBanner chart's image
Aldeyra Therapeutics
Price$5.34
Change+$0.09 (+1.71%)
Volume$393.03K
Capitalization320.64M
MeiraGTx Holdings
Price$7.93
Change+$0.10 (+1.28%)
Volume$296.52K
Capitalization637.95M
ALDX vs MGTX Comparison Chart in %
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. MGTX commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and MGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (ALDX: $5.34 vs. MGTX: $7.93)
Brand notoriety: ALDX and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 51% vs. MGTX: 84%
Market capitalization -- ALDX: $320.64M vs. MGTX: $637.95M
ALDX [@Biotechnology] is valued at $320.64M. MGTX’s [@Biotechnology] market capitalization is $637.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 5 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 6 bearish.
  • MGTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -4.81% price change this week, while MGTX (@Biotechnology) price change was -6.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

ALDX is expected to report earnings on Nov 13, 2025.

MGTX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($638M) has a higher market cap than ALDX($321M). MGTX YTD gains are higher at: 30.213 vs. ALDX (7.014). ALDX has higher annual earnings (EBITDA): -48.46M vs. MGTX (-132.21M). ALDX has more cash in the bank: 81.9M vs. MGTX (32.2M). ALDX has less debt than MGTX: ALDX (15.6M) vs MGTX (80.5M). MGTX has higher revenues than ALDX: MGTX (37.9M) vs ALDX (0).
ALDXMGTXALDX / MGTX
Capitalization321M638M50%
EBITDA-48.46M-132.21M37%
Gain YTD7.01430.21323%
P/E RatioN/AN/A-
Revenue037.9M-
Total Cash81.9M32.2M254%
Total Debt15.6M80.5M19%
FUNDAMENTALS RATINGS
ALDX vs MGTX: Fundamental Ratings
ALDX
MGTX
OUTLOOK RATING
1..100
1513
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3840
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (39) in the Biotechnology industry is somewhat better than the same rating for MGTX (94). This means that ALDX’s stock grew somewhat faster than MGTX’s over the last 12 months.

ALDX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that ALDX’s stock grew similarly to MGTX’s over the last 12 months.

ALDX's SMR Rating (98) in the Biotechnology industry is in the same range as MGTX (100). This means that ALDX’s stock grew similarly to MGTX’s over the last 12 months.

ALDX's Price Growth Rating (38) in the Biotechnology industry is in the same range as MGTX (40). This means that ALDX’s stock grew similarly to MGTX’s over the last 12 months.

ALDX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that ALDX’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXMGTX
RSI
ODDS (%)
Bearish Trend 8 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 8 days ago
85%
Momentum
ODDS (%)
Bullish Trend 8 days ago
84%
Bearish Trend 8 days ago
83%
MACD
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 8 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
85%
Bearish Trend 8 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
80%
Bullish Trend 8 days ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 21 days ago
79%
Bearish Trend 20 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
78%
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bearish Trend 8 days ago
87%
Bullish Trend 8 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HGTXU0.340.02
+6.13%
Hugoton Royalty Trust
BKFCF0.83N/A
N/A
Bank of Communications Co. Ltd.
PPTTF12.10N/A
N/A
Perpetual Ltd
WTBDY10.85-0.02
-0.19%
Whitbread Plc
PBNK20.25-0.10
-0.49%
Pinnacle Bank

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+1.71%
GSGTF - ALDX
56%
Loosely correlated
N/A
PLRX - ALDX
38%
Loosely correlated
+1.34%
ARVN - ALDX
37%
Loosely correlated
-3.98%
CGON - ALDX
35%
Loosely correlated
-0.26%
MGTX - ALDX
32%
Poorly correlated
+1.28%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with IDYA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+1.28%
IDYA - MGTX
50%
Loosely correlated
+1.12%
AURA - MGTX
47%
Loosely correlated
+0.49%
NUVL - MGTX
46%
Loosely correlated
-5.67%
RGNX - MGTX
46%
Loosely correlated
-0.79%
KRRO - MGTX
45%
Loosely correlated
+0.15%
More